4.69
price down icon2.90%   -0.14
 
loading
전일 마감가:
$4.83
열려 있는:
$4.83
하루 거래량:
553.00K
Relative Volume:
1.38
시가총액:
$106.29M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-4.9894
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
-26.03%
1개월 성능:
-30.52%
6개월 성능:
-33.00%
1년 성능:
+53.27%
1일 변동 폭
Value
$4.67
$5.05
1주일 범위
Value
$4.67
$6.61
52주 변동 폭
Value
$2.77
$12.23

Exagen Inc Stock (XGN) Company Profile

Name
명칭
Exagen Inc
Name
전화
(760) 560-1501
Name
주소
1261 LIBERTY WAY, VISTA, CA
Name
직원
209
Name
트위터
@ExagenInc
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
XGN's Discussions on Twitter

XGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
XGN
Exagen Inc
4.69 109.46M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
618.72 234.69B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
235.99 169.45B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
715.37 56.86B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
237.68 41.09B 15.90B 1.28B 2.21B 7.2842
Diagnostics & Research icon
A
Agilent Technologies Inc
139.64 41.06B 6.95B 1.30B 1.15B 4.5696

Exagen Inc Stock (XGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-11 개시 B. Riley Securities Buy
2025-07-30 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2025-07-23 개시 Craig Hallum Buy
2022-08-05 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 재개 Cowen Outperform
2021-04-15 개시 Canaccord Genuity Buy
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-08 개시 BTIG Research Buy
2020-06-02 재개 Cantor Fitzgerald Overweight
2019-10-14 개시 Cantor Fitzgerald Overweight
2019-10-14 개시 Cowen Outperform
2019-10-14 개시 William Blair Outperform
모두보기

Exagen Inc 주식(XGN)의 최신 뉴스

pulisher
Jan 15, 2026

Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm

Jan 15, 2026
pulisher
Jan 15, 2026

Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm

Jan 15, 2026
pulisher
Jan 14, 2026

Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Published on: 2026-01-13 10:11:31 - Улправда

Jan 13, 2026
pulisher
Jan 13, 2026

Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail

Jan 13, 2026
pulisher
Jan 12, 2026

How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance

Jan 12, 2026
pulisher
Jan 12, 2026

Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks

Jan 12, 2026
pulisher
Jan 12, 2026

Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada

Jan 12, 2026
pulisher
Jan 12, 2026

California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer

Jan 12, 2026
pulisher
Jan 11, 2026

Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus

Jan 11, 2026
pulisher
Jan 11, 2026

Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative

Jan 11, 2026
pulisher
Jan 11, 2026

Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph

Jan 11, 2026
pulisher
Jan 11, 2026

Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan

Jan 11, 2026
pulisher
Jan 09, 2026

Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How ImmunityBio Inc. stock trades before earningsJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is MIMI stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk High Reward Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda ru > 2026> Is BPYPO stock dividend yield sustainableMarket Risk Analysis & Fast Entry High Yield Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. (E08A) stock rise with strong economyMarket Risk Analysis & Daily Risk Controlled Trade Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What momentum indicators show for Exagen Inc. stock2025 Big Picture & Weekly High Return Stock Opportunities - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. stock benefit from AI adoption2025 Volatility Report & Verified Short-Term Plans - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

How Exagen Inc. stock reacts to job market dataTrade Execution Strategies & Free Rapid Portfolio Appreciation - Улправда

Jan 07, 2026
pulisher
Jan 06, 2026

Why Exagen Inc stock could rally in 2025Market Risk Analysis & Real-Time Price Movement Reports - Bộ Nội Vụ

Jan 06, 2026
pulisher
Jan 06, 2026

Free cash flow per share of Exagen, Inc. – SWB:E08A - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 03, 2026

Exagen Inc E08A Stock Analysis and ForecastTrendline Breakouts & Compound Your Gains With Quality Stocks - earlytimes.in

Jan 03, 2026
pulisher
Jan 02, 2026

XGN Stock Price, Forecast & Analysis | EXAGEN INC (NASDAQ:XGN) - Chartmill

Jan 02, 2026
pulisher
Dec 31, 2025

American Bio Medica (OTCMKTS:ABMC) versus Exagen (NASDAQ:XGN) Head-To-Head Comparison - Defense World

Dec 31, 2025
pulisher
Dec 29, 2025

Will Exagen Inc. stock see PE expansionFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com

Dec 29, 2025
pulisher
Dec 29, 2025

Will Exagen Inc. stock benefit from automationDividend Yield Trends & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com

Dec 29, 2025
pulisher
Dec 26, 2025

Aug Closing: How rising interest rates impact CZFS stockWeekly Market Outlook & Free Accurate Trade Setup Notifications - moha.gov.vn

Dec 26, 2025
pulisher
Dec 22, 2025

How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades - Yahoo Finance

Dec 22, 2025
pulisher
Dec 21, 2025

Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Dec 21, 2025
pulisher
Dec 21, 2025

What Wall Street predicts for Exagen Inc. stock price2025 Pullback Review & Fast Entry Momentum Alerts - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 20, 2025
pulisher
Dec 19, 2025

Is Exagen Inc. (E08A) stock among top earnings playsQuarterly Market Summary & Trade Opportunity Analysis - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Exagen Inc. stock dividend yield sustainable2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Exagen Inc. stock weather global recessionSwing Trade & Daily Technical Forecast Reports - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Will Exagen Inc. (E08A) stock gain from green policiesJuly 2025 Sector Moves & Verified Momentum Watchlists - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Is Exagen Inc. stock trading at a premium valuationQuarterly Earnings Summary & Weekly Hot Stock Watchlists - Улправда

Dec 18, 2025

Exagen Inc (XGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Exagen Inc 주식 (XGN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Black Jeffrey G.
Chief Financial Officer
Sep 02 '25
Sale
9.79
20,466
200,362
269,026
NMSIC Co-Investment Fund, L.P.
10% Owner
Mar 25 '25
Sale
3.30
350,000
1,155,000
1,758,958
$141.65
price down icon 2.51%
diagnostics_research LH
$270.87
price up icon 0.74%
diagnostics_research WAT
$387.37
price down icon 1.83%
diagnostics_research MTD
$1,460.63
price down icon 2.40%
$231.25
price down icon 3.78%
diagnostics_research A
$139.64
price down icon 3.58%
자본화:     |  볼륨(24시간):